JNGLX
Price
$65.52
Change
+$0.68 (+1.05%)
Updated
Apr 23 closing price
Net Assets
4.71B
LHCQX
Price
$17.36
Change
+$0.28 (+1.64%)
Updated
Apr 23 closing price
Net Assets
7.12M
Ad is loading...

JNGLX vs LHCQX

Header iconJNGLX vs LHCQX Comparison
Open Charts JNGLX vs LHCQXBanner chart's image
Janus Henderson Global Life Sciences D
Price$65.52
Change+$0.68 (+1.05%)
VolumeN/A
Net Assets4.71B
Lord Abbett Health Care R3
Price$17.36
Change+$0.28 (+1.64%)
VolumeN/A
Net Assets7.12M
JNGLX vs LHCQX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JNGLX vs. LHCQX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNGLX is a Buy and LHCQX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 4.71B vs. LHCQX (7.12M). LHCQX pays higher dividends than JNGLX: LHCQX (0.36) vs JNGLX (0.34). JNGLX was incepted earlier than LHCQX: JNGLX (26 years) vs LHCQX (6 years). LHCQX (3.78) is less costly to investors than JNGLX (0.80). LHCQX is a more actively managed with annual turnover of: 88.00 vs. JNGLX (35.00). LHCQX has a lower initial minimum investment than JNGLX: LHCQX (0) vs JNGLX (2500). LHCQX annual gain was more profitable for investors over the last year : -5.85 vs. JNGLX (-8.95). JNGLX return over 5 years is better than : 11.21 vs. LHCQX (5.51).
JNGLXLHCQXJNGLX / LHCQX
Total Expense Ratio0.801.2863%
Annual Report Gross Expense Ratio0.803.7821%
Fund Existence26 years6 years-
Gain YTD-4.493-9.53447%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets4.71B7.12M66,240%
Annual Yield % from dividends0.340.3695%
Returns for 1 year-8.95-5.85153%
Returns for 3 years2.64-0.43-609%
Returns for 5 years11.215.51203%
Returns for 10 years8.49N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MIDSX1.97N/A
N/A
Midas
SHSCX48.37N/A
N/A
BlackRock Health Sciences Opps Inv C
NRSRX45.36N/A
N/A
Neuberger Berman Sustainable Equity R6
SUSYX13.79N/A
N/A
SEI US Managed Volatility Y (SIMT)
CILGX14.41N/A
N/A
Clarkston Institutional